H.R. 2179 · 117th Congress · House

Affordable Insulin for the COVID–19 Emergency Act

Active· Referred to the Subcommittee on Health.
Introduced
Mar 23, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Affordable Insulin for the COVID-19 Emergency Act

This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.

Action Timeline

6
  1. MAR 24, 2021•Committee

    Referred to the Subcommittee on Health.

  2. MAR 23, 2021•IntroReferral

    Introduced in House

  3. MAR 23, 2021•IntroReferral

    Introduced in House

  4. MAR 23, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. MAR 23, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. MAR 23, 2021•Committee

    Referred to the Subcommittee on Health.

Committees

4

Health Subcommittee

hsif14

Referred: Mar 24, 2021

Active

Health Subcommittee

hswm02

Referred: Mar 23, 2021

Active

Ways and Means Committee

hswm00

Referred: Mar 23, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Mar 23, 2021

Active